Research Finds AI Holds Great Potential in Early Prediction of Breast Cancer


Meituan launched "Xiaotuan Health Manager", entering the AI healthcare sector by combining family health management with its existing delivery network and expanding service boundaries through AI technology.
Meyuan Health and Ant Health have reached a strategic cooperation, combining the offline health check network and digital ecosystem advantages to jointly create an AI-driven health screening, diagnosis, and long-term management service loop. Meyuan Health has nearly 600 health check centers nationwide, serving approximately 30 million people annually, and is advancing its "All in AI" strategy, with AI business revenue reaching about 250 million yuan in the first three quarters of 2025.
A minimally invasive robot company successfully completed the world's first autonomous surgery experiment using a large model on animals, marking the beginning of a new era of autonomous-driven surgical robots. The experiment was based on the company's self-developed neuron-based MicroGenius multimodal large model, filling the technical gap in this field.
As part of the Midea Group, Midea Medical has launched a self-owned intellectual property multimodal intelligent diagnostic large model for medical imaging, achieving a key breakthrough in AI healthcare. The model can automatically detect common chest diseases such as tuberculosis, pneumonia, pneumothorax, and fractures in one go, and generate structured diagnostic reports, significantly improving the efficiency and diagnostic consistency of image review in grassroots medical institutions.
2025 marks a breakthrough growth for AI healthcare. The overseas platform OpenEvidence has secured $250 million in funding, with its valuation reaching $12 billion; Ant Group has also launched an upgraded health AI product, indicating a promising industry outlook.